Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06629090 · ClinicalTrials.gov registry record · Phase 2
Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort
A Phase 2 study of Magnetic Resonance Imaging and Cerebrovascular Circulation, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06629090: Recruiting Phase 2 study of Magnetic Resonance Imaging and Cerebrovascular Circulation, sponsored by University of Wisconsin, Madison.
NCT06629090 is a Phase 2 study of Magnetic Resonance Imaging and Cerebrovascular Circulation that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 36 participants, below the 157-participant average among 20 other Magnetic Resonance Imaging trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06629090, a Phase 2 study of Magnetic Resonance Imaging and Cerebrovascular Circulation, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.
Primary Outcome
The change in blood velocity during breathing and simulated postural change tasks will be measured with MRI
Conditions Studied
Interventions
- DRUG Placebo
- DEVICE MRI
- DRUG Prazosin
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
What NCT06629090 shows while recruiting
NCT06629090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 157-participant average among 20 other Magnetic Resonance Imaging trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Magnetic Resonance Imaging appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06629090 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06629090 about?
NCT06629090 is a clinical study titled "Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort". Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.
What is the current status of trial NCT06629090?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2025-12-17. Estimated completion is 2026-12.
What conditions does trial NCT06629090 study?
This clinical trial studies the following conditions: Magnetic Resonance Imaging, Cerebrovascular Circulation.
What interventions are being tested in trial NCT06629090?
The interventions under investigation include: Placebo (DRUG), MRI (DEVICE), Prazosin (DRUG).
Who is sponsoring clinical trial NCT06629090?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06629090 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Magnetic Resonance Imaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06629090's enrollment target sits among peer trials
36 16th of 20 higher than 4 of 20 other Magnetic Resonance Imaging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Magnetic Resonance Imaging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain Blood Vessel Responses to Changes in Blood Flow
RECRUITING · Phase 2
-
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
RECRUITING · Phase 2
-
Effect of Nutritional Ketosis on Alcohol Metabolism
RECRUITING · Phase 2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Study of New Magnetic Resonance Imaging Methods of the Brain
RECRUITING
-
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI